Three-dimensional conformal arc radiotherapy using a C-arm linear accelerator with a computed tomography on-rail system for prostate cancer: clinical outcomes
Authors:
- Atsuhiro KumabeAKAtsuhiro Kumabe
- Noboru FukuharaNFNoboru Fukuhara
- Takuji UtsunomiyaTUTakuji Utsunomiya
- Takatsugu KawaseTKTakatsugu Kawase
- Kunihiro IwataKIKunihiro Iwata
- Yukinori OkadaYOYukinori Okada
- Shinya SutaniSSShinya Sutani
- Toshio OhashiTOToshio Ohashi
- Mototsugu OyaMOMototsugu Oya
- Naoyuki ShigematsuNSNaoyuki Shigematsu
Open Access
- 12 October 2015
- journal article
- research article
- Published by Springer Nature in Radiation Oncology
- Vol. 10 (1) , 208
Abstract
We report the feasibility and treatment outcomes of image-guided three-dimensional conformal arc radiotherapy (3D-CART) using a C-arm linear accelerator with a computed tomography (CT) on-rail system for localized prostate cancer. Between 2006 and 2011, 282 consecutive patients with localized prostate cancer were treated with in-room CT-guided 3D-CART. Biochemical failure was defined as a rise of at least 2.0 ng/ml beyond the nadir prostate-specific antigen level. Toxicity was scored according to the National Cancer Institute Common Terminology Criteria for Adverse Events, version 4.0. A total of 261 patients were analyzed retrospectively (median follow-up: 61.6 months). The median prescribed 3D-CART dose was 82 Gy (2 Gy/fraction, dose range: 78–86 Gy), and 193 of the patients additionally received hormonal therapy. The 5-year overall survival rate was 93.9 %. Among low-, intermediate-, and high-risk patients, 5-year rates of freedom from biochemical failure were 100, 91.5 and 90.3 %, respectively. Rates of grade 2–3 late gastrointestinal and genitourinary toxicities were 2.3 and 11.4 %, respectively. No patient experienced late grade 4 or higher toxicity. In-room CT-guided 3D-CART was feasible and effective for localized prostate cancer. Treatment outcomes were comparable to those previously reported for intensity-modulated radiotherapy.Keywords
This publication has 31 references indexed in Scilit:
- Long-Term Toxicity Following 3D Conformal Radiation Therapy for Prostate Cancer From the RTOG 9406 Phase I/II Dose Escalation StudyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Multi-institutional analysis of long-term outcome for stages T1–T2 prostate cancer treated with permanent seed implantationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Long-Term Outcome of High Dose Intensity Modulated Radiation Therapy for Patients With Clinically Localized Prostate CancerJournal of Urology, 2006
- Technological advances in external-beam radiation therapy for the treatment of localized prostate cancerSeminars in Oncology, 2003
- Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen eraCancer, 2002
- Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate CancerJAMA, 1998
- Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directionsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998
- Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998
- Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: A strategy for large-scale implementation for the treatment of carcinoma of the prostateInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1997